Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience

European Urology

Volumn 57, Issue 5, 2010, Pages 843-849

  Mariappan, Paramananthan ^a   Zachou, Alexandra ^a   Grigor, Kenneth M ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Detrusor muscle; Quality control; Recurrence; Transurethral resection of bladder tumour (TURBT)

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CLINICAL COMPETENCE; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; DATA BASE; DETRUSOR MUSCLE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE RESECTION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITY CONTROL; RECURRENCE RISK; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; BIOLOGICAL MARKERS; CLINICAL COMPETENCE; CYSTECTOMY; FEMALE; HUMANS; MALE; MUSCLE, SMOOTH; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY CONTROL; RISK ASSESSMENT; TIME FACTORS; URETHRA; URINARY BLADDER NEOPLASMS;

EID: 77949487097     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.05.047     Document Type: Article

References (19)

1. Babjuk M., Oosterlinck W., Sylvester R.J., Kaasinen E., Bohle A., and Palou J. Guidelines on TaT1 (non-muscle invasive) bladder cancer (2009), European Association of Urology, Arnhem, Netherlands. http://www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/TaT1_BC.pdf
2. Carmack A.J., and Soloway M.S. The diagnosis and staging of bladder cancer: from RBCs to TURs. Urology 67 Suppl 1 (2006) 3-8 discussion 8-10
3. Kurth K. Natural history and prognosis of untreated and treated superficial bladder cancer (1997), Isis Medical Media, Oxford, UK
4. Mariappan P., Smith G., Lamb A.D.G., Grigor K.M., and Tolley D.A. Pattern of recurrence changes in noninvasive bladder tumours observed during 2 decades. J Urol 77 (2007) 867-875
5. Brausi M., Collette L., Kurth K., et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41 (2002) 523-531
6. Herr H.W., and Donat S.M. A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 97 (2005) 1194-1198
7. Grimm M.-O., Steinhoff C., Simon X., Spiegelhalder P., Ackermann R., and Vogeli A.T. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 170 (2003) 433-437
8. Brauers A., Buettner R., and Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?. J Urol 165 (2001) 808-810
9. Herr H.W., and Donat S.M. Quality control in transurethral resection of bladder tumours. BJU Int 102 (2008) 1242-1246
10. Maruniak N., Takezawa K., and Murphy W. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol 167 (2002) 2404-2407
11. Dalbagni G., Herr H.W., and Reuter V. Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 60 (2002) 822-825
12. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumours. J Urol 162 (1999) 74-76
13. Dutta S.C., Smith J.A.J., Shappell S.B., Coffey C.S., Chang S.S., and Cookson M.S. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166 (2001) 490-493
14. Nieder A.M., Brausi M., Lamm D., et al. Management of stage T1 tumours of the bladder: International Consensus Panel. Urology 66 Suppl 1 (2005) 108-125
15. Manoharan M., and Soloway M.S. Optimal management of the T1G3 bladder cancer. Urol Clin North Am 32 (2005) 133-145
16. Brausi M.A., Gavioli M., Peracchia G., et al. Dedicated teaching programs can improve the quality of TUR of non-muscle-invasive bladder tumours (NMIBT): experience of a single institution. Eur Urol Suppl 7 (2008) 180
17. Jesuraj M.G., Harris M., Rogers A., and Whiteway J.E. Completeness of the first resection of bladder tumour depending on the seniority of the surgeon. Eur Urol Suppl 7 (2008) 138
18. Balbay D.M., Ersin C., Unsal A., Bayrak O., Koc A., and Akbulut Z. The actual incidence of bladder perforation following transurethral bladder surgery. J Urol 174 (2005) 2260-2263
19. Skolarikos A., Chrisofos M., Ferakis N., Papatsoris A., Dellis A., and Deliveliotis C. Does the management of bladder perforation during transurethral resection of superficial bladder tumours predispose to extravesical tumour recurrence?. J Urol 173 (2005) 1908-1911